Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06536283

Opiophobia in Postsurgical Adults With Cancer

To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Opiophobia

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The Univerisity of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

About this study

To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer who were prescribed opioids for home use during the first week following hospital discharge for a surgical treatment of a malignancy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient with cancer admitted for cancer-related surgery
  • inpatient surgical hospital stay lasting at least 23 hours
  • discharged home with a prescription for opioid analgesics
  • able to read, speak, and consent in English.

Exclusion criteria

  • Age less than 18 years
  • not discharged with a prescription for opioid analgesia to manage pain
  • individuals for whom there is documentation of inability to provide consent in the medical record.

Treatment and study plan

13-item Barriers Questionnaire (BQ-13)

Other

Given by questionnaire

Four-item Medication Adherence Questionnaire

Other

Given by questionnaire

14-item Hospital Anxiety and Depression Scale (HADS)

Other

Given by questionnaire

Primary outcomes

  1. To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer.

    Time frame: Through study completion, an average of 1 year.

    Use of opioids among a population of adults who underwent surgery for cancer.

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Collaborators

  • Sigma Theta Tau International

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Aug 2, 2024
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.